Free Trial

Sangamo Therapeutics (SGMO) Short Interest Ratio & Short Volume

$0.44
-0.01 (-2.20%)
(As of 06/21/2024 ET)

Sangamo Therapeutics Short Interest Data

Current Short Interest
12,800,000 shares
Previous Short Interest
14,730,000 shares
Change Vs. Previous Month
-13.10%
Dollar Volume Sold Short
$7.22 million
Short Interest Ratio
6.8 Days to Cover
Last Record Date
May 31, 2024
Outstanding Shares
207,510,000 shares
Percentage of Shares Shorted
6.17%
Today's Trading Volume
2,257,481 shares
Average Trading Volume
1,722,771 shares
Today's Volume Vs. Average
131%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Sangamo Therapeutics ?

Sign up to receive the latest short interest report for Sangamo Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

SGMO Short Interest Over Time

SGMO Days to Cover Over Time

SGMO Percentage of Float Shorted Over Time

Sangamo Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/31/202412,800,000 shares $7.22 million -13.1%N/A6.8 $0.56
5/15/202414,730,000 shares $8.54 million +2.6%N/A7.4 $0.58
4/30/202414,360,000 shares $7.39 million +8.4%N/A6.2 $0.51
4/15/202413,250,000 shares $7.36 million +16.1%N/A5.6 $0.56
3/31/202411,410,000 shares $7.65 million +4.9%N/A4.9 $0.67
3/15/202410,880,000 shares $8.49 million +8.2%N/A4.6 $0.78
2/29/202410,060,000 shares $11.67 million +3.4%N/A4.7 $1.16
2/15/20249,730,000 shares $10.22 million -2.5%N/A4.8 $1.05
1/31/20249,980,000 shares $4.56 million +9.0%N/A6 $0.46
1/15/20249,160,000 shares $4.72 million +0.2%N/A5.5 $0.52
12/31/20239,140,000 shares $4.97 million -0.8%N/A4.9 $0.54
12/15/20239,210,000 shares $3.82 million -4.9%N/A4.3 $0.42
11/30/20239,680,000 shares $4.16 million -6.1%N/A4.7 $0.43
11/15/202310,310,000 shares $3.77 million -11.0%N/A4.9 $0.37
10/31/202311,590,000 shares $7.30 million +10.4%N/A6.1 $0.63
10/15/202310,500,000 shares $5.88 million +15.3%N/A5.9 $0.56
9/30/20239,110,000 shares $5.46 million -5.2%N/A4.9 $0.60
9/15/20239,610,000 shares $9.60 million -8.1%N/A6.3 $1.00
8/31/202310,460,000 shares $10.14 million -2.5%N/A5.5 $0.97
8/15/202310,730,000 shares $10.84 million -1.5%N/A5.1 $1.01
7/31/202310,890,000 shares $14.32 million -5.2%N/A4.7 $1.32
7/15/202311,490,000 shares $14.82 million -4.0%N/A4.6 $1.29
6/30/202311,970,000 shares $15.56 million -19.2%N/A4.7 $1.30
6/15/202314,820,000 shares $17.19 million +1.9%N/A5.6 $1.16
5/31/202314,540,000 shares $16.28 million -17.4%N/A6.3 $1.12
5/15/202317,610,000 shares $23.60 million -12.9%N/A7.5 $1.34
4/30/202320,220,000 shares $29.72 million +3.8%14.1%9.5 $1.47
4/15/202319,490,000 shares $32.16 million +4.4%13.6%10 $1.65
3/31/202318,670,000 shares $32.86 million +13.8%14.2%10.5 $1.76
3/15/202316,410,000 shares $35.45 million +38.1%12.5%10.1 $2.16
2/28/202311,880,000 shares $36.23 million +2.2%9.0%7.8 $3.05
2/15/202311,620,000 shares $34.86 million -2.5%9.1%8.6 $3.00
1/31/202311,920,000 shares $41.60 million -0.8%9.3%8.8 $3.49
1/15/202312,010,000 shares $43.72 million -2.8%9.4%8.7 $3.64
12/30/202212,360,000 shares $38.81 million +11.0%9.6%9 $3.14
12/15/202211,140,000 shares $36.76 million -1.2%8.7%8.1 $3.30
11/30/202211,270,000 shares $41.25 million -0.7%8.9%8.3 $3.66
11/15/202211,350,000 shares $44.38 million -6.5%9.0%8 $3.91
10/31/202212,140,000 shares $53.29 million +1.3%8.8%8.4 $4.39
10/15/202211,980,000 shares $55.47 million +9.4%9.1%8.3 $4.63
Wall Street destroyed my wife’s retirement. Here’s how we saved it. (Ad)

How we rebuilt my wife's retirement

Everything you need to know is right here.
9/30/202210,950,000 shares $53.66 million +17.5%8.3%7.4 $4.90
9/15/20229,320,000 shares $54.06 million +5.6%7.1%6.1 $5.80
8/31/20228,830,000 shares $47.68 million -6.8%6.8%5.5 $5.40
8/15/20229,470,000 shares $60.51 million -4.9%7.3%5.6 $6.39
7/31/20229,960,000 shares $42.73 million -3.5%8.2%5.6 $4.29
7/15/202210,320,000 shares $46.85 million -3.0%8.5%5.9 $4.54
6/30/202210,640,000 shares $44.05 million +1.3%8.8%6.2 $4.14
6/15/202210,500,000 shares $36.23 million +4.9%10.3%6.2 $3.45
5/31/202210,010,000 shares $36.54 million +16.9%8.2%6.7 $3.65
5/15/20228,560,000 shares $34.41 million +6.2%7.0%6.1 $4.02
4/30/20228,060,000 shares $33.45 million +2.8%6.6%6.4 $4.15
4/15/20227,840,000 shares $41.24 million +2.8%6.5%6.4 $5.26
3/31/20227,630,000 shares $44.33 million +8.7%6.3%5.8 $5.81
3/15/20227,020,000 shares $36.78 million -3.7%5.8%5.2 $5.24
2/28/20227,290,000 shares $42.65 million -15.2%6.0%5.2 $5.85
2/15/20228,600,000 shares $51.60 million +2.1%7.1%5.9 $6.00
1/31/20228,420,000 shares $50.77 million -4.0%7.0%6 $6.03
1/15/20228,770,000 shares $56.13 million -1.9%7.3%5.7 $6.40
12/31/20218,940,000 shares $67.05 million -1.3%7.4%6.3 $7.50
12/15/20219,060,000 shares $70.22 million -13.8%7.5%6.9 $7.75
11/30/202110,510,000 shares $87.13 million +1.6%8.7%8.8 $8.29
11/15/202110,350,000 shares $101.64 million +2.2%8.6%9 $9.82
10/29/202110,130,000 shares $82.26 million -0.7%8.4%9.4 $8.12
10/15/202110,200,000 shares $89.25 million -2.5%8.5%12 $8.75
9/30/202110,460,000 shares $94.24 million -2.2%8.7%12 $9.01
9/15/202110,690,000 shares $97.92 million -6.3%8.9%11.3 $9.16
8/31/202111,410,000 shares $113.07 million -3.5%9.5%11.9 $9.91
8/13/202111,820,000 shares $118.79 million -1.3%9.8%12.9 $10.05
7/30/202111,980,000 shares $114.77 million -3.0%10.0%12.9 $9.58
7/15/202112,350,000 shares $121.40 million +4.5%10.4%12.7 $9.83
6/30/202111,820,000 shares $141.49 million -13.9%9.9%11.9 $11.97
6/15/202113,730,000 shares $154.74 million -5.2%11.5%13.7 $11.27
5/28/202114,480,000 shares $156.09 million -4.4%12.2%13.3 $10.78
5/14/202115,150,000 shares $157.56 million -0.2%N/A12.3 $10.40
4/30/202115,180,000 shares $180.64 million -5.3%N/A11.2 $11.90
4/15/202116,030,000 shares $186.59 million -3.0%N/A11.1 $11.64
3/31/202116,520,000 shares $192.79 million -0.2%N/A10.8 $11.67
3/15/202116,560,000 shares $191.10 million +6.0%N/A8.8 $11.54
2/26/202115,620,000 shares $174.79 million +0.4%N/A6.6 $11.19
2/12/202115,560,000 shares $215.66 million -0.7%N/A6.7 $13.86
1/29/202115,670,000 shares $222.36 million -6.6%N/A6.6 $14.19
1/15/202116,770,000 shares $271.51 million -2.5%N/A7.1 $16.19
12/31/202017,200,000 shares $289.99 million -1.6%N/A7.4 $16.86
12/15/202017,470,000 shares $228.51 million -13.4%N/A7.9 $13.08
11/30/202020,180,000 shares $204.22 million +4.0%N/A13.3 $10.12
11/15/202019,410,000 shares $222.83 million -4.7%N/A13 $11.48
10/30/202020,370,000 shares $216.13 million -3.4%N/A13.6 $10.61
10/15/202021,090,000 shares $237.47 million -1.2%N/A13.2 $11.26
9/30/202021,350,000 shares $201.76 million +9.1%N/A13.1 $9.45
9/15/202019,570,000 shares $208.81 million +4.4%N/A11.4 $10.67
Wall Street destroyed my wife’s retirement. Here’s how we saved it. (Ad)

How we rebuilt my wife's retirement

Everything you need to know is right here.
8/31/202018,750,000 shares $206.81 million -3.1%N/A9.2 $11.03
8/14/202019,340,000 shares $220.28 million +4.4%N/A9.2 $11.39
7/31/202018,520,000 shares $200.57 million -0.2%N/A8.2 $10.83
7/15/202018,550,000 shares $197.19 million -5.7%N/A8.5 $10.63
6/30/202019,660,000 shares $172.42 million +15.0%N/A8.6 $8.77
6/15/202017,100,000 shares $187.76 million +5.9%N/A7.3 $10.98
5/29/202016,150,000 shares $180.72 million -3.1%14.6%6.8 $11.19
5/15/202016,660,000 shares $167.27 million +2.8%15.0%6.1 $10.04
4/30/202016,210,000 shares $138.43 million -3.8%17.7%6.5 $8.54
4/15/202016,850,000 shares $122.67 million +1.8%18.4%6.9 $7.28
3/31/202016,560,000 shares $137.78 million 0.0%N/A6.9 $8.32
3/13/202016,566,600 shares $123.59 million -5.5%N/A4.2 $7.46
2/28/202017,530,000 shares $102.90 million -0.9%N/A8.2 $5.87
2/14/202017,680,000 shares $134.19 million -4.5%N/A10.6 $7.59
1/31/202018,510,000 shares $127.35 million +6.5%N/A11.2 $6.88
1/15/202017,380,000 shares $132.09 million +1.9%N/A10.8 $7.60
12/31/201917,050,000 shares $127.88 million +1.0%N/A11 $7.50

SGMO Short Interest - Frequently Asked Questions

What is Sangamo Therapeutics' current short interest?

Short interest is the volume of Sangamo Therapeutics shares that have been sold short but have not yet been closed out or covered. As of May 31st, investors have sold 12,800,000 shares of SGMO short. Learn More on Sangamo Therapeutics' current short interest.

What is a good short interest ratio for Sangamo Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SGMO shares currently have a short interest ratio of 7.0. Learn More on Sangamo Therapeutics's short interest ratio.

Is Sangamo Therapeutics' short interest increasing or decreasing?

Sangamo Therapeutics saw a drop in short interest in the month of May. As of May 31st, there was short interest totaling 12,800,000 shares, a drop of 13.1% from the previous total of 14,730,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Sangamo Therapeutics' short interest compare to its competitors?

Here is how the short interest of companies in the sector of "medical" compare to Sangamo Therapeutics: bluebird bio, Inc. (26.63%), Cellectis S.A. (0.76%), Atara Biotherapeutics, Inc. (233.82%), Adaptimmune Therapeutics plc (1.87%), Emergent BioSolutions Inc. (11.81%), Agenus Inc. (13.68%), XOMA Co. (2.30%), Codexis, Inc. (2.88%), Achieve Life Sciences, Inc. (2.77%), Regulus Therapeutics Inc. (4.90%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.43 billion), Charter Communications, Inc. ($3.54 billion), Occidental Petroleum Co. ($3.11 billion), Moderna, Inc. ($2.88 billion), General Motors ($2.62 billion), Royal Caribbean Cruises Ltd. ($2.34 billion), Coinbase Global, Inc. ($2.25 billion), Tractor Supply ($2.12 billion), Dell Technologies Inc. ($1.89 billion), and Enphase Energy, Inc. ($1.72 billion). View all of the most shorted stocks.

What does it mean to sell short Sangamo Therapeutics stock?

Short selling SGMO is an investing strategy that aims to generate trading profit from Sangamo Therapeutics as its price is falling. SGMO shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Sangamo Therapeutics?

A short squeeze for Sangamo Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SGMO, which in turn drives the price of the stock up even further.

How often is Sangamo Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SGMO, twice per month. The most recent reporting period available is May, 31 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:SGMO) was last updated on 6/22/2024 by MarketBeat.com Staff

From Our Partners